Impairment of NK cell function by NKG2D modulation in NOD mice

Immunity

Volumn 18, Issue 1, 2003, Pages 41-51

  Ogasawara, Kouetsu ^a   Hamerman, Jessica A ^a   Hsin, Honor ^b   Chikuma, Shunsuke ^b   Bour Jordan, Helene ^b   Chen, Taian ^a   Pertel, Thomas ^a   Carnaud, Claude ^c   Bluestone, Jeffrey A ^b   Lanier, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; LIGAND;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0037241472     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00505-8     Document Type: Article

References (43)

1. Abrams S.I., Brahmi Z. Target cell directed NK inactivation. Concomitant loss of NK and antibody-dependent cellular cytotoxicity activities. J. Immunol. 140:1988;2090-2095.
2. Attallah A.M., Abdelghaffar H., Fawzy A., Alghraoui F., Alijani M.R., Mahmoud L.A., Ghoneim M.A., Helfrich G.B. Cell-mediated immunity and biological response modifiers in insulin- dependent diabetes mellitus complicated by end-stage renal disease. Int. Arch. Allergy Appl. Immunol. 83:1987;278-283.
3. Bach J.F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15:1994;516-542.
4. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of natural killer cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:1999;727-730.
5. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense. function and regulation by innate cytokines Annu. Rev. Immunol. 17:1999;189-220.
6. Brodsky F.M., Chen C.Y., Knuehl C., Towler M.C., Wakeham D.E. Biological basket weaving. formation and function of clathrin-coated vesicles Annu. Rev. Cell Dev. Biol. 17:2001;517-568.
7. Cameron M.J., Meagher C., Delovitch T.L. Failure in immune regulation begets IDDM in NOD mice. Diabetes Metab. Rev. 14:1998;177-185.
8. Carnaud C., Gombert J., Donnars O., Garchon H., Herbelin A. Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex. J. Immunol. 166:2001;2404-2411.
9. Castano L., Eisenbarth G.S. Type-I diabetes. a chronic autoimmune disease of human, mouse, and rat Annu. Rev. Immunol. 8:1990;647-679.
10. Cefai D., Schneider H., Matangkasombut O., Kang H., Brody J., Rudd C.E. CD28 receptor endocytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and costimulation. J. Immunol. 160:1998;2223-2230.
11. Cerwenka A., Lanier L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1:2001;41-49.
12. Cerwenka A., Bakker A.B., McClanahan T., Wagner J., Wu J., Phillips J.H., Lanier L.L. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 12:2000;721-727.
13. Chang C., Dietrich J., Harpur A.G., Lindquist J.A., Haude A., Loke Y.W., King A., Colonna M., Trowsdale J., Wilson M.J. Cutting edge. KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties J. Immunol. 163:1999;4651-4654.
14. Ghosh S., Palmer S.M., Rodrigues N.R., Cordell H.J., Hearne C.M., Cornall R.J., Prins J.B., McShane P., Lathrop G.M., Peterson L.B.et al. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat. Genet. 4:1993;404-409.
15. Groh V., Wu J., Yee C., Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature. 419:2002;734-738.
16. Ho E.L., Heusel J.W., Brown M.G., Matsumoto K., Scalzo A.A., Yokoyama W.M. Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells. Proc. Natl. Acad. Sci. USA. 95:1998;6320-6325.
17. Jamieson A.M., Diefenbach A., McMahon C.W., Xiong N., Carlyle J.R., Raulet D.H. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity. 17:2002;19-29.
18. Jewett A., Bonavida B. Target-induced anergy of natural killer cytotoxic function is restricted to the NK-target conjugate subset. Cell. Immunol. 160:1995;91-97.
19. Kataoka S., Satoh J., Fujiya H., Toyota T., Suzuki R., Itoh K., Kumagai K. Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes. 32:1983;247-253.
20. Kinsella T.M., Nolan G.P. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7:1996;1405-1413.
21. Lanier L.L. NK cell receptors. Annu. Rev. Immunol. 16:1998;359-393.
22. Mizuki N., Ota M., Kimura M., Ohno S., Ando H., Katsuyama Y., Yamazaki M., Watanabe K., Goto K., Nakamura S.et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene. a strong association of six GCT repetitions with Behcet disease Proc. Natl. Acad. Sci. USA. 94:1997;1298-1303.
23. Nair M.P., Lewis E.W., Schwartz S.A. Immunoregulatory dysfunctions in type I diabetes. natural and antibody-dependent cellular cytotoxic activities J. Clin. Immunol. 6:1986;363-372.
24. Negishi K., Waldeck N., Chandy G., Buckingham B., Kershnar A., Fisher L., Gupta S., Charles M.A. Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes. Diabetologia. 29:1986;352-357.
25. Norris S., Kondeatis E., Collins R., Satsangi J., Clare M., Chapman R., Stephens H., Harrison P., Vaughan R., Donaldson P. Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis. the role of MICA polymorphism Gastroenterology. 120:2001;1475-1482.
26. Ogasawara K., Yoshinaga S.K., Lanier L.L. Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells. J. Immunol. 169:2002;3676-3685.
27. Onihsi M., Kinoshita S., Morikawa Y., Shibuya A., Phillips J., Lanier L.L., Gorman D.M., Nolan G.P., Miyajima A., Kitamura T. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 24:1996;324-329.
28. Perussia B., Trinchieri G. Inactivation of natural killer cell cytotoxic activity after interaction with target cells. J. Immunol. 126:1981;754-758.
29. Poulton L.D., Smyth M.J., Hawke C.G., Silveira P., Shepherd D., Naidenko O.V., Godfrey D.I., Baxter A.G. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol. 13:2001;887-896.
30. Rapoport I., Miyazaki M., Boll W., Duckworth B., Cantley L.C., Shoelson S., Kirchhausen T. Regulatory interactions in the recognition of endocytic sorting signals by AP-2 complexes. EMBO J. 16:1997;2240-2250.
31. Rogner U.C., Boitard C., Morin J., Melanitou E., Avner P. Three loci on mouse chromosome 6 influence onset and final incidence of type I diabetes in NOD.C3H congenic strains. Genomics. 74:2001;163-171.
32. Schneider H., Martin M., Agarraberes F.A., Yin L., Rapoport I., Kirchhausen T., Rudd C.E. Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2. J. Immunol. 163:1999;1868-1879.
33. Shultz L.D., Schweitzer P.A., Christianson S.W., Gott B., Schweitzer I.B., Tennent B., McKenna S., Mobraaten L., Rajan T.V., Greiner D.L.et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154:1995;180-191.
34. Sorkin A., Carpenter G. Interaction of activated EGF receptors with coated pit adaptins. Science. 261:1993;612-615.
35. Sugimura K., Ota M., Matsuzawa J., Katsuyama Y., Ishizuka K., Mochizuki T., Mizuki N., Seki S.S., Honma T., Inoko H., Asakura H. A close relationship of triplet repeat polymorphism in MHC class I chain-related gene A (MICA) to the disease susceptibility and behavior in ulcerative colitis. Tissue Antigens. 57:2001;9-14.
36. Timonen T., Saksela E., Ranki A., Hayry P. Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. Cell. Immunol. 48:1979;133-148.
37. Touitou I., Picot M.C., Domingo C., Notarnicola C., Cattan D., Demaille J., Kone-Paut I. The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum. 44:2001;163-169.
38. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47:1989;187-376.
39. Wallace G.R., Verity D.H., Delamaine L.J., Ohno S., Inoko H., Ota M., Mizuki N., Yabuki K., Kondiatis E., Stephens H.A.et al. MIC-A allele profiles and HLA class I associations in Behcet's disease. Immunogenetics. 49:1999;613-617.
40. Wicker L.S., Todd J.A., Peterson L.B. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:1995;179-200.
41. Wu J., Song Y., Bakker A.B.H., Bauer S., Groh V., Spies T., Lanier L.L., Phillips J.H. An activating receptor complex on natural killer and T cells formed by NKG2D and DAP10. Science. 285:1999;730-732.
42. Wu J., Cherwinski H., Spies T., Phillips J.H., Lanier L.L. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J. Exp. Med. 192:2000;1059-1068.
43. Yokoyama W.M., Seaman W.E. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells. The NK gene complex Annu. Rev. Immunol. 11:1993;613-635.